[go: up one dir, main page]

DE69926504D1 - Zubereitungen zur kontrollierten freisetzung mit mehrschichtstruktur - Google Patents

Zubereitungen zur kontrollierten freisetzung mit mehrschichtstruktur

Info

Publication number
DE69926504D1
DE69926504D1 DE69926504T DE69926504T DE69926504D1 DE 69926504 D1 DE69926504 D1 DE 69926504D1 DE 69926504 T DE69926504 T DE 69926504T DE 69926504 T DE69926504 T DE 69926504T DE 69926504 D1 DE69926504 D1 DE 69926504D1
Authority
DE
Germany
Prior art keywords
preparations
degradable
drugs
dispersed
controlled release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69926504T
Other languages
English (en)
Other versions
DE69926504T2 (de
Inventor
Akihiko Sano
Masako Kajihara
Toshihiko Sugie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Pharma Co Ltd
Original Assignee
Sumitomo Pharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Pharmaceuticals Co Ltd filed Critical Sumitomo Pharmaceuticals Co Ltd
Application granted granted Critical
Publication of DE69926504D1 publication Critical patent/DE69926504D1/de
Publication of DE69926504T2 publication Critical patent/DE69926504T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69926504T 1998-05-29 1999-05-19 Zubereitungen zur kontrollierten freisetzung mit mehrschichtstruktur Expired - Lifetime DE69926504T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP14859198 1998-05-29
JP14859198 1998-05-29
PCT/JP1999/002594 WO1999062501A1 (en) 1998-05-29 1999-05-19 Controlled release preparations having multi-layer structure

Publications (2)

Publication Number Publication Date
DE69926504D1 true DE69926504D1 (de) 2005-09-08
DE69926504T2 DE69926504T2 (de) 2006-06-08

Family

ID=15456186

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69926504T Expired - Lifetime DE69926504T2 (de) 1998-05-29 1999-05-19 Zubereitungen zur kontrollierten freisetzung mit mehrschichtstruktur

Country Status (17)

Country Link
US (1) US7101567B1 (de)
EP (1) EP1084703B1 (de)
JP (1) JP4459444B2 (de)
KR (1) KR100584632B1 (de)
CN (1) CN1165294C (de)
AT (1) ATE300939T1 (de)
AU (1) AU752952B2 (de)
BR (1) BR9910793B1 (de)
CA (1) CA2333555C (de)
DE (1) DE69926504T2 (de)
DK (1) DK1084703T3 (de)
ES (1) ES2245827T3 (de)
NZ (1) NZ508400A (de)
PT (1) PT1084703E (de)
TW (1) TW586944B (de)
WO (1) WO1999062501A1 (de)
ZA (1) ZA200006829B (de)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100402053B1 (ko) * 2000-09-28 2003-10-17 한국화학연구원 항생제의 서방성 임플란트 제제
MXPA03003933A (es) * 2000-11-03 2003-08-19 Biomedicines Inc Metodo para dosimetria de farmaco de duracion corta y duracion prolongada.
EP1250933A1 (de) * 2001-04-17 2002-10-23 Istituto Superiore di Sanità Impfstoffe mit hochdosiertem Typ I IFN als Adjuvans
AU2002365436B8 (en) * 2001-11-09 2008-04-03 Intarcia Therapeutics, Inc. Method for treating diseases with omega interferon
WO2003068604A1 (en) * 2002-02-13 2003-08-21 Weibel Michael K Drug dose-form and method of manufacture
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
US20040249364A1 (en) * 2003-06-03 2004-12-09 Ilya Kaploun Device and method for dispensing medication to tissue lining a body cavity
WO2006078320A2 (en) 2004-08-04 2006-07-27 Brookwood Pharmaceuticals, Inc. Methods for manufacturing delivery devices and devices thereof
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
JP5143131B2 (ja) 2006-05-30 2013-02-13 インターシア セラピューティクス，インコーポレイティド 浸透圧送出システムの二片構成内部チャネル型の流れモジュレータ
AU2007284759B2 (en) 2006-08-09 2010-10-28 Intarcia Therapeutics, Inc. Osmotic delivery systems and piston assemblies
WO2008060360A2 (en) * 2006-09-28 2008-05-22 Surmodics, Inc. Implantable medical device with apertures for delivery of bioactive agents
CN101715340A (zh) 2007-04-23 2010-05-26 精达制药公司 促胰岛素释放肽的混悬制剂及其应用
US8394391B2 (en) * 2007-08-31 2013-03-12 University Of Utah Research Foundation Drug delivery vehicle that mimics viral properties
AR066166A1 (es) * 2007-09-21 2009-07-29 Organon Nv Sistema de suministro de droga
US8728528B2 (en) 2007-12-20 2014-05-20 Evonik Corporation Process for preparing microparticles having a low residual solvent volume
US8343140B2 (en) 2008-02-13 2013-01-01 Intarcia Therapeutics, Inc. Devices, formulations, and methods for delivery of multiple beneficial agents
US20100068254A1 (en) * 2008-09-16 2010-03-18 Mahalaxmi Gita Bangera Modifying a medicament availability state of a final dosage form
US20100068153A1 (en) * 2008-09-16 2010-03-18 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Ex vivo activatable final dosage form
US20100068275A1 (en) * 2008-09-16 2010-03-18 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Personalizable dosage form
US20100068152A1 (en) * 2008-09-16 2010-03-18 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Ex vivo modifiable particle or polymeric based final dosage form
US20100068266A1 (en) * 2008-09-16 2010-03-18 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Ex vivo-modifiable multiple-release state final dosage form
US20100068235A1 (en) * 2008-09-16 2010-03-18 Searete LLC, a limited liability corporation of Deleware Individualizable dosage form
US12478503B2 (en) 2009-05-18 2025-11-25 Glaukos Corporation Implants with controlled drug delivery features and methods of using same
US10206813B2 (en) 2009-05-18 2019-02-19 Dose Medical Corporation Implants with controlled drug delivery features and methods of using same
CN105726201B (zh) 2009-05-18 2020-08-25 多斯医学公司 给药眼植入物
WO2012071476A2 (en) 2010-11-24 2012-05-31 David Haffner Drug eluting ocular implant
WO2011037953A2 (en) * 2009-09-22 2011-03-31 Surmodics Pharmaceuticals, Inc. Implant devices having varying bioactive agent loading configurations
KR102093612B1 (ko) 2009-09-28 2020-03-26 인타르시아 세라퓨틱스 인코포레이티드 실질 항정상태 약물 전달의 신속 확립 및/또는 종결
SG184059A1 (en) 2010-03-16 2012-10-30 Titan Pharmaceuticals Inc Heterogeneous implantable devices for drug delivery
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
EP2750666B1 (de) * 2011-08-30 2017-10-04 Universiteit Gent Mehrschichtige formulierungsfreisetzung
US10517759B2 (en) 2013-03-15 2019-12-31 Glaukos Corporation Glaucoma stent and methods thereof for glaucoma treatment
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
AU2016270984B2 (en) 2015-06-03 2021-02-25 Intarcia Therapeutics, Inc. Implant placement and removal systems
WO2017040853A1 (en) 2015-09-02 2017-03-09 Glaukos Corporation Drug delivery implants with bi-directional delivery capacity
WO2017053885A1 (en) 2015-09-25 2017-03-30 Glaukos Corporation Punctal implants with controlled drug delivery features and methods of using same
AU2017252294B2 (en) 2016-04-20 2021-12-02 Glaukos Corporation Bioresorbable ocular drug delivery device
RU2760007C2 (ru) 2016-05-16 2021-11-22 Интарсия Терапьютикс, Инк. Полипептиды, селективные к рецепторам глюкагона, и способы их применения
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
CA3049034A1 (en) 2017-01-03 2018-07-12 Intarcia Therapeutics, Inc. Methods comprising continuous administration of a glp-1 receptor agonist and co-adminstration of a drug
CN110538158A (zh) * 2019-09-10 2019-12-06 郑州百瑞动物药业有限公司 一种水产用长效缓释双层片状消毒剂及其制备方法
CN114699512B (zh) * 2022-04-02 2024-05-28 贵州医科大学 一种甲状旁腺激素缓释药物及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4351337A (en) 1973-05-17 1982-09-28 Arthur D. Little, Inc. Biodegradable, implantable drug delivery device, and process for preparing and using the same
US4191741A (en) * 1978-09-22 1980-03-04 Eli Lilly And Company Removable drug implant
US4601893A (en) * 1984-02-08 1986-07-22 Pfizer Inc. Laminate device for controlled and prolonged release of substances to an ambient environment and method of use
JPS62174031A (ja) * 1985-10-11 1987-07-30 Sumitomo Pharmaceut Co Ltd 高分子量薬物含有徐放性製剤
NZ217844A (en) 1985-10-11 1989-10-27 Sumitomo Pharma A sustained release pharmaceutical composition containing silicone elastomer and an albumin
DE3684446D1 (de) * 1985-12-28 1992-04-23 Sumitomo Pharma Arzneimittel mit verzoegerter stossweiser freisetzung.
US4846844A (en) 1987-08-31 1989-07-11 Eli Lilly And Company Antimicrobial coated implants
JP3118009B2 (ja) * 1991-04-16 2000-12-18 住友製薬株式会社 多層構造を有するコラーゲンおよび／またはゼラチン製剤の製造方法
JP3720386B2 (ja) * 1993-12-27 2005-11-24 住友製薬株式会社 薬物放出制御製剤
FR2729539B1 (fr) * 1995-01-23 1997-04-11 Virbac Lab Dispositif a liberation controlee de substances chimiques, destine a etre fixe sur un animal et procede de preparation dudit dispositif
US5558879A (en) * 1995-04-28 1996-09-24 Andrx Pharmaceuticals, Inc. Controlled release formulation for water soluble drugs in which a passageway is formed in situ

Also Published As

Publication number Publication date
ES2245827T3 (es) 2006-01-16
DE69926504T2 (de) 2006-06-08
AU752952B2 (en) 2002-10-03
CA2333555A1 (en) 1999-12-09
ZA200006829B (en) 2001-09-04
BR9910793A (pt) 2001-02-13
KR20010043683A (ko) 2001-05-25
DK1084703T3 (da) 2005-08-29
ATE300939T1 (de) 2005-08-15
EP1084703B1 (de) 2005-08-03
EP1084703A4 (de) 2002-04-03
EP1084703A1 (de) 2001-03-21
PT1084703E (pt) 2005-11-30
JP4459444B2 (ja) 2010-04-28
NZ508400A (en) 2002-10-25
TW586944B (en) 2004-05-11
CN1303277A (zh) 2001-07-11
CA2333555C (en) 2008-02-26
AU3848799A (en) 1999-12-20
US7101567B1 (en) 2006-09-05
KR100584632B1 (ko) 2006-05-30
WO1999062501A1 (en) 1999-12-09
CN1165294C (zh) 2004-09-08
BR9910793B1 (pt) 2010-12-14

Similar Documents

Publication Publication Date Title
DE69926504D1 (de) Zubereitungen zur kontrollierten freisetzung mit mehrschichtstruktur
DE69811278D1 (de) Gegen magensaft geschützte omeprazol-mikrogranülen, herstellungsverfahren und pharmazeutische zubereitungen
ES2023649B3 (es) Formas de dosificacion y administracion para medicamentos, reactivos o similares asi como procedimiento para su obtencion.
DE3887712D1 (de) Absorbierendes Material, versehen mit quellbarem Wirkstoff, und dieses Material enthaltende Produkte.
DE3865631D1 (de) Darreichungsform mit kontrollierter freigabe.
NO880314D0 (no) Farmaseutisk transportmiddel.
ATE357265T1 (de) Ladung und abgabe von wasser unlöslicher arzneimittel
IT1282576B1 (it) Compressa farmaceutica atta a cedere la sostanza attiva in tempi successivi e predeterminabili
PT644771E (pt) Sistema de entrega da droga eritropoietina
DE19882362T1 (de) Mikropartikel, geeignet als Ultraschallkontrastmittel und zum Transport von Arzneimitteln in den Blutstrom
EP1413327A4 (de) Stent
CA2327649A1 (en) Small bore biologic graft with therapeutic delivery system
FR2784583B1 (fr) Composition pharmaceutique a residence gastrique et a liberation controlee
AR009696A2 (es) Dispositivo inhalador para administrar un polvo seco medicamentoso, procedimiento para su realizacion y envase de burbujas para ser usado con dicho dispositivo.
DK0735849T3 (da) Tynde hygiejneprodukter med et præfabrikeret, absorberende legeme
DK1112739T3 (da) Langtidsafgivende depot-præparat
ATE428495T1 (de) Stoffe zur enternung von cannabinoiden und säulen mit diesen stoffen zur entfernung von cannabinoiden
DE69809745D1 (de) Absorbierender wegwerfartikel mit kleidungsähnlichen, äusseren schichten, welche unterschiedliche atmungsfähigkeiten besitzen und die methode solche schichten herzustellen
FR2638234B1 (fr) Support pour molecules biologiquement actives ou lui-meme biologiquement actif, son procede de preparation et son application en biologie
MATVEEVA et al. Psychological studies of TV-communications
YU47062B (sh) Postupak za pravljenje malih perli koje sadrže lek

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: DAINIPPON SUMITOMO PHARMA CO., LTD., OSAKA, JP

8364 No opposition during term of opposition